Trademark: 85335395
Status Date
Monday, May 9, 2016
Filing Date
Wednesday, June 1, 2011
Published for Opposition
Tuesday, February 5, 2013
Abandoned Date
Monday, May 9, 2016
5 Reagents for medical and clinical diagnosis purposes; medicines for in-vitro diagnosis; reagents for medical and veterinary genetic testing; medical diagnostic reagents comprised of genetic chips for clinical diagnosis; reagents for medical treatment purposes, namely, for detecting gene polymorphisms; reagents for medical treatment purposes, namely, for DNA extraction; reagents for medical treatment purposes, namely, for DNA amplification; reagents for medical treatment purposes, namely, for selecting best course medical treatment including identifying infectious agents, vulnerability against specific disease, and selecting most effective and least adverse effect medicine; reagents for gene analysis for medical treatment purposes, namely, for selecting best course medical treatment including identifying infectious agents, vulnerability against specific disease, and selecting most effective and least adverse effect medicine
9 DNA chips for medical diagnosis; computer software for genetic analysis for medical purposes; computer software for use in medical testing and diagnosis, namely, computer software for detecting single-nucleotide polymorphisms, somatic mutations and specific sequences for medical diagnosis
10 In vitro analysis apparatus and instruments primarily for detecting single-nucleotide polymorphisms, somatic mutations and specific sequences; medical diagnostic apparatus for determining appropriate medical treatment based on genetic analysis of patient morbidity and physical condition; clinical chemical analysis devices comprising automatic dispensers, DNA extracting units, fluorescent detecting units and thermostats; medical diagnostic apparatus comprised primarily of DNA chips and DNA extracting cartridges for genetic analysis of patients; medical diagnostic apparatus for the genetic analysis of single-nucleotide polymorphisms, somatic mutations, nucleic acids, proteins, chemical compounds, oligonucleotides, and polypeptides samples; medical diagnostic apparatus for the genetic analysis of biological matter extracted from humans and animals
Color is not claimed as a feature of the mark.
May 9, 2016
Abandonment Notice Mailed - No Use Statement Filed
May 9, 2016
Abandonment - No Use Statement Filed
Oct 15, 2015
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2015
Extension 5 Granted
Sep 30, 2015
Extension 5 Filed
Oct 13, 2015
Case Assigned To Intent To Use Paralegal
Sep 30, 2015
Teas Extension Received
Feb 25, 2015
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2015
Extension 4 Granted
Feb 3, 2015
Extension 4 Filed
Feb 3, 2015
Teas Extension Received
Feb 3, 2015
Teas Change Of Correspondence Received
Sep 20, 2014
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2014
Extension 3 Granted
Sep 11, 2014
Extension 3 Filed
Sep 11, 2014
Teas Extension Received
Apr 18, 2014
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2014
Extension 2 Granted
Mar 20, 2014
Extension 2 Filed
Apr 14, 2014
Case Assigned To Intent To Use Paralegal
Mar 20, 2014
Teas Extension Received
Jul 25, 2013
Notice Of Approval Of Extension Request E-Mailed
Jul 23, 2013
Extension 1 Granted
Jul 23, 2013
Extension 1 Filed
Jul 23, 2013
Teas Extension Received
Apr 2, 2013
Noa E-Mailed - Sou Required From Applicant
Feb 5, 2013
Official Gazette Publication Confirmation E-Mailed
Feb 5, 2013
Published For Opposition
Jan 16, 2013
Notification Of Notice Of Publication E-Mailed
Jan 3, 2013
Law Office Publication Review Completed
Jan 2, 2013
Exparte Appeal Terminated
Jan 2, 2013
Approved For Pub - Principal Register
Nov 14, 2012
Teas/Email Correspondence Entered
Nov 14, 2012
Correspondence Received In Law Office
Nov 9, 2012
Teas Request For Reconsideration Received
Nov 9, 2012
Ex Parte Appeal-Instituted
Nov 9, 2012
Jurisdiction Restored To Examining Attorney
Nov 9, 2012
Exparte Appeal Received At Ttab
May 9, 2012
Notification Of Final Refusal Emailed
May 9, 2012
Final Refusal E-Mailed
May 9, 2012
Final Refusal Written
Apr 12, 2012
Teas/Email Correspondence Entered
Apr 12, 2012
Correspondence Received In Law Office
Apr 12, 2012
Teas/Email Correspondence Entered
Mar 16, 2012
Correspondence Received In Law Office
Mar 30, 2012
Assigned To Lie
Mar 23, 2012
Teas Voluntary Amendment Received
Mar 16, 2012
Teas Response To Office Action Received
Sep 16, 2011
Notification Of Non-Final Action E-Mailed
Sep 16, 2011
Non-Final Action E-Mailed
Sep 16, 2011
Non-Final Action Written
Sep 16, 2011
Assigned To Examiner
Jun 6, 2011
New Application Office Supplied Data Entered In Tram
Jun 4, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
